Home › Funds › PFM Health Sciences, LP › VKTX

PFM Health Sciences, LP position in VKTX

VIKING THERAPEUTICS INC · Health Care

PFM Health Sciences, LP reported holding 255,330 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$10.0M, representing 0.87% of its reported portfolio and ranking #43 among its reported holdings. PFM Health Sciences, LP has disclosed VKTX holdings in 7 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)255.33K sh
Reported value held$9.96M
Portfolio Weight0.87%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's VKTX position evolved

PFM Health Sciences, LP first disclosed a stake in VKTX in Q1 2024 at 32,827 shares (US$2.7M). The position peaked in Q2 2026 at 255,330 shares, worth US$10.0M. Across 7 filings, PFM Health Sciences, LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 255,330 shares valued at US$10.0M — a reduction of -7,776 shares quarter over quarter.. Notable position changes include a 79% increase in Q2 2024 (shares rose 19% over the following quarter), a 386% increase in Q3 2025 (shares rose 34% over the following quarter), a 39% increase in Q1 2026 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 32.83K $2.69M New
Q2 2024 58.81K $3.12M Add
Q2 2025 37.73K $999.82K New
Q3 2025 183.54K $4.82M Add
Q4 2025 188.96K $6.65M Add
Q1 2026 263.11K $8.56M Add
Q2 2026 255.33K $9.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VKTX and 13F data

VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VKTX

All VKTX fund holders →

FAQ

How long has PFM Health Sciences, LP held VKTX?

PFM Health Sciences, LP has disclosed VKTX holdings in 7 of the last 10 reported quarters, going back to Q1 2024.

What is PFM Health Sciences, LP's current position in VKTX?

As of Q2 2026, PFM Health Sciences, LP holds 255.33K shares of VKTX (VIKING THERAPEUTICS INC), valued at $9.96M, representing 0.87% of its reported portfolio and ranking #43.

Has PFM Health Sciences, LP been buying or selling VKTX?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in VKTX. The position peaked in Q2 2026 at 255.33K shares.

Which other funds hold VKTX?

Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.